Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
PEACE-3 is a strong example of how academic cooperative research can help advance progress for complex diseases such as metastatic prostate cancer
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
The approval follows the pivotal Phase III ARANOTE trial, which demonstrated that darolutamide plus ADT cut the risk of radiological progression or death by 46% compared to placebo plus ADT
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
All pending litigation between Biocon Biologics, Regeneron, and Bayer will be dismissed
The positive CHMP opinion is supported by results from the Phase III QUASAR trial
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Subscribe To Our Newsletter & Stay Updated
